The upregulation of this gene observed in our experimental data may indicate favorable mechanism of these compounds on CTSB gene expression by increasing the activity of the enzyme and elevating clearance of Aβ, thus provide therapeutic potential in AD. The gene discussed is CTSB; the disease is Alzheimer disease.